Author Archive
-
Jul 26, 2024The pricing process for biopharmaceutical products is complex and poorly understood by the mainstream media and, more importantly, the general public. For example, few people... -
Jan 26, 2024In a turbulent and divided political environment, few issues enjoy bipartisan support. Among the issues most deserving of common action are reforms to the 340B Drug Pricing Program,...
